查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1685167

血液氣體和電解質分析儀市場機會、成長動力、產業趨勢分析和預測 2025 - 2034

Blood Gas and Electrolyte Analyzers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球血氣和電解質分析儀市場規模達到 19 億美元，預計 2025 年至 2034 年期間的複合年成長率為 5.2%。這一成長是由糖尿病、呼吸系統疾病、腎臟疾病和心血管疾病等慢性病的日益流行所推動的，所有這些疾病都需要頻繁監測血氣和電解質水平。醫療保健提供者擴大採用這些分析儀來確保準確、及時的診斷結果，從而改善重症監護環境中的患者治療效果。對即時診斷解決方案不斷成長的需求也在市場擴張中發揮了關鍵作用，醫院、急診和重症監護室 (ICU) 都依賴這些設備進行即時決策。

血氣和電解質分析儀市場 - IMG1

技術的進步改變了血液氣體和電解質測試格局，使其更加方便和高效。攜帶式和手持式分析儀的發展使得醫療保健專業人員能夠在患者床邊進行測試，最大限度地減少診斷和治療的延誤。此外，自動化和與電子健康記錄 (EHR) 的整合簡化了工作流程，減少了錯誤並提高了效率。對早期疾病檢測和個人化醫療的日益重視進一步推動了對這些分析儀的需求，因為它們能夠對重症患者進行持續監測和早期干預。此外，醫療保健基礎設施投資的不斷成長，加上全球人口老化，推動了先進診斷工具的採用，使得這個市場對製造商和利害關係人來說非常有利可圖。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 19億美元
預測值 31億美元
複合年成長率 5.2％

市場分為攜帶式和桌上型分析儀，其中攜帶式設備預計將實現大幅成長。攜帶式市場預計將以 5.4% 的複合年成長率擴張，到 2034 年將達到 20 億美元。這一成長主要得益於對即時診斷測試需求的不斷成長，特別是在急診室、ICU 和門診護理設施中，快速準確的結果對於患者管理至關重要。攜帶式分析儀具有移動性、易用性和周轉時間更快的優勢，使臨床醫生無需進行集中實驗室測試即可做出及時的決策。家庭醫療保健和遠端病人監控的成長趨勢進一步增加了對這些小型設備的需求，使得在傳統醫療保健環境之外進行即時診斷成為可能。

就最終用途而言，市場涵蓋即時檢驗、中央實驗室、診斷中心、醫院和其他醫療機構。由於重症監護環境中對快速、精確的診斷工具的迫切需求，即時診斷部分將在 2024 年佔據 35.5% 的市場佔有率。這些分析儀在急診室、手術室和重症監護室中發揮著至關重要的作用，即時的檢測結果可以挽救生命。他們能夠在患者床邊提供即時見解，從而顯著縮短週轉時間、提高工作流程效率並確保及時介入。 POC 分析儀在門診和家庭醫療保健環境中的廣泛應用進一步鞏固了其在市場中的地位。

2024 年美國血氣和電解質分析儀市場規模達到 6.636 億美元，預計 2025 年至 2034 年的複合年成長率為 5%。糖尿病、心血管疾病和呼吸系統疾病等慢性病發病率的增加是推動市場成長的主要因素。這些情況需要持續監測血液氣體和電解質水平，從而推動對可靠、有效的診斷解決方案的需求。此外，美國老齡化人口面臨更高的慢性和急性健康問題風險，導致醫院、診所和家庭醫療保健機構更多地採用這些分析儀。對基於價值的護理的日益關注，加上 POC 測試技術的進步，預計將進一步加速美國市場的擴張，使其成為行業參與者的主要收入來源。

目錄

第 1 章：方法論與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 全球慢性病盛行率不斷上升
      • 技術進步
      • 對整合系統的需求不斷增加
    • 產業陷阱與挑戰
      • 產品成本高
  • 成長潛力分析
  • 監管格局
  • 技術格局
  • 差距分析
  • 定價分析
  • 波特的分析
  • PESTEL 分析
  • 未來市場趨勢

第4章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第 5 章：市場估計與預測：按設備類型，2021 - 2034 年

  • 主要趨勢
  • 便攜的
  • 桌上型

第 6 章：市場估計與預測：按產品類型，2021 - 2034 年

  • 主要趨勢
  • 耗材
  • 組合分析儀
  • 電解質分析儀
  • 血氣分析儀

第 7 章：市場估計與預測：按最終用途，2021 - 2034 年

  • 主要趨勢
  • 照護端
  • 中央實驗室
  • 診斷中心
  • 醫院
  • 其他最終用戶

第 8 章：市場估計與預測：按地區，2021 - 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第9章：公司簡介

  • Abbott
  • Convergent Technologies
  • Cornley
  • EDAN
  • Erba Mannheim
  • Fortress Diagnostics
  • Medica
  • nova biomedical
  • OPTI Medical
  • RADIOMETER
  • Roche
  • SENSA CORE
  • SIEMENS Healthineers
  • Tecom
  • Werfen
簡介目錄
Product Code: 428

The Global Blood Gas And Electrolyte Analyzers Market reached USD 1.9 billion in 2024 and is projected to expand at a CAGR of 5.2% between 2025 and 2034. This growth is fueled by the increasing prevalence of chronic conditions such as diabetes, respiratory disorders, kidney diseases, and cardiovascular ailments, all of which require frequent monitoring of blood gas and electrolyte levels. Healthcare providers are increasingly adopting these analyzers to ensure precise and timely diagnostic results, improving patient outcomes in critical care settings. The rising demand for point-of-care (POC) diagnostic solutions has also played a key role in market expansion, with hospitals, emergency departments, and intensive care units (ICUs) relying on these devices for real-time decision-making.

Blood Gas and Electrolyte Analyzers Market - IMG1

Advancements in technology have transformed the blood gas and electrolyte testing landscape, making it more accessible and efficient. The development of portable and handheld analyzers has allowed healthcare professionals to conduct tests at the patient's bedside, minimizing delays in diagnosis and treatment. Additionally, automation and integration with electronic health records (EHRs) have streamlined workflows, reducing errors and improving efficiency. The increasing emphasis on early disease detection and personalized medicine is further driving the demand for these analyzers, as they enable continuous monitoring and early intervention in critically ill patients. Moreover, the growing investments in healthcare infrastructure, coupled with an aging global population, are pushing the adoption of advanced diagnostic tools, making this market highly lucrative for manufacturers and stakeholders.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$ 1.9 Billion
Forecast Value$ 3.1 Billion
CAGR5.2%

The market is segmented into portable and benchtop analyzers, with portable devices expected to see substantial growth. The portable segment is projected to expand at a CAGR of 5.4%, reaching USD 2 billion by 2034. This surge is primarily driven by the rising demand for point-of-care testing, particularly in emergency rooms, ICUs, and ambulatory care facilities, where rapid and accurate results are critical for patient management. Portable analyzers offer the advantage of mobility, ease of use, and faster turnaround times, allowing clinicians to make prompt decisions without the need for centralized laboratory testing. The growing trend of home healthcare and remote patient monitoring is further increasing the demand for these compact devices, enabling real-time diagnostics outside traditional healthcare settings.

In terms of end-use, the market spans point-of-care testing, central laboratories, diagnostic centers, hospitals, and other healthcare facilities. The point-of-care segment accounted for 35.5% of the market share in 2024, driven by the urgent need for fast and precise diagnostic tools in critical care settings. These analyzers play a crucial role in emergency rooms, operating rooms, and ICUs, where immediate test results can be life-saving. Their ability to deliver real-time insights at the patient's bedside significantly reduces turnaround time, improving workflow efficiency and ensuring timely interventions. The expanding use of POC analyzers in ambulatory care and home healthcare settings is further solidifying their position in the market.

The U.S. blood gas and electrolyte analyzers market reached USD 663.6 million in 2024, with an anticipated growth rate of 5% CAGR from 2025 to 2034. The increasing incidence of chronic diseases such as diabetes, cardiovascular disorders, and respiratory conditions is a major factor propelling market growth. These conditions require continuous monitoring of blood gas and electrolyte levels, driving demand for reliable and efficient diagnostic solutions. Additionally, the aging population in the U.S. faces a higher risk of both chronic and acute health issues, leading to greater adoption of these analyzers in hospitals, clinics, and home healthcare settings. The growing focus on value-based care, coupled with advancements in POC testing technologies, is expected to further accelerate the expansion of the U.S. market, making it a key revenue generator for industry players.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of chronic disease worldwide
      • 3.2.1.2 Technological advancements
      • 3.2.1.3 Increasing demand for integrated system
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost associated with product
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Gap analysis
  • 3.7 Pricing analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Future market trends

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Portable
  • 5.3 Benchtop

Chapter 6 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Consumables
  • 6.3 Combined analyzers
  • 6.4 Electrolyte analyzers
  • 6.5 Blood gas analyzers

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Point-of-care
  • 7.3 Central laboratories
  • 7.4 Diagnostic centers
  • 7.5 Hospitals
  • 7.6 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Abbott
  • 9.2 Convergent Technologies
  • 9.3 Cornley
  • 9.4 EDAN
  • 9.5 Erba Mannheim
  • 9.6 Fortress Diagnostics
  • 9.7 Medica
  • 9.8 nova biomedical
  • 9.9 OPTI Medical
  • 9.10 RADIOMETER
  • 9.11 Roche
  • 9.12 SENSA CORE
  • 9.13 SIEMENS Healthineers
  • 9.14 Tecom
  • 9.15 Werfen